Neoadjuvant GTX Chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer

MLA

Jason B. Klapman, et al. “Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer.” Journal of Surgical Oncology, vol. 104, Apr. 2011, pp. 155–61. EBSCOhost, https://doi.org/10.1002/jso.21954.

APA

Jason B. Klapman, Sarah E. Hoffe, Mokenge P. Malafa, James Helm, Gregory M. Springett, Tiffany Valone, Barbara A. Centeno, Pamela Hodul, Jongphil Kim, & Manish Patel. (2011). Neoadjuvant GTX Chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. Journal of Surgical Oncology, 104, 155–161. https://doi.org/10.1002/jso.21954

Chicago

Jason B. Klapman, Sarah E. Hoffe, Mokenge P. Malafa, James Helm, Gregory M. Springett, Tiffany Valone, Barbara A. Centeno, Pamela Hodul, Jongphil Kim, and Manish Patel. 2011. “Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer.” Journal of Surgical Oncology 104 (April): 155–61. doi:10.1002/jso.21954.